UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 5.106

Sortiert nach

Comparative analysis of DNA extraction and PCR product purification methods for cervicovaginal microbiome analysis using cpn60 microbial profiling

PloS one, 2022-01, Vol.17 (1), p.e0262355-e0262355

2022

Volltextzugriff (PDF)

Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial

Blood cancer journal (New York), 2016-12, Vol.6 (12), p.e506-e506

2016

Volltextzugriff (PDF)

Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles

Leukemia, 2010-01, Vol.24 (1), p.58-65

2010

Volltextzugriff (PDF)

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data

Bone marrow transplantation (Basingstoke), 2011-01, Vol.46 (1), p.52-58

2011

Volltextzugriff (PDF)

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide

Leukemia, 2017-11, Vol.31 (11), p.2347-2354

2017

Volltextzugriff (PDF)

Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia

Leukemia, 2010-01, Vol.24 (1), p.74-80

2010

Volltextzugriff (PDF)

Gardnerella subgroup dominant microbiomes are associated with divergent cervicovaginal immune responses in a longitudinal cohort of Kenyan women

Frontiers in immunology, 2023-01, Vol.13, p.974195-974195

2023

Volltextzugriff (PDF)

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

Bone marrow transplantation (Basingstoke), 2008-12, Vol.42 (12), p.783-789

2008

Volltextzugriff (PDF)

The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry

Leukemia, 2010-10, Vol.24 (10), p.1725-1731

2010

Volltextzugriff (PDF)

Acute disseminated encephalomyelitis following allo-SCT: central nervous system manifestation of GVHD

Bone marrow transplantation (Basingstoke), 2014-06, Vol.49 (6), p.854-856

2014

Volltextzugriff (PDF)

DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412

Leukemia, 2006-12, Vol.20 (12), p.2130-2136

2006

Volltextzugriff (PDF)

Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2005-09, Vol.36 (5), p.437-441

2005

Volltextzugriff (PDF)

Primary Transplantation of Allogeneic Peripheral Blood Progenitor Cells Mobilized by Filgrastim (Granulocyte Colony-Stimulating Factor)

Blood, 1995-03, Vol.85 (6), p.1666-1672

1995

Volltextzugriff (PDF)

Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia

Leukemia, 2017-05, Vol.31 (5), p.1059-1068

2017

Volltextzugriff (PDF)

Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant

Bone marrow transplantation (Basingstoke), 2008-03, Vol.41 (5), p.495-503

2008

Volltextzugriff (PDF)

Interleukin-1β maintains an apoptosis-resistant phenotype in the blast cells of acute myeloid leukaemia via multiple pathways

Leukemia, 2004-10, Vol.18 (10), p.1662-1670

2004

Volltextzugriff (PDF)

The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison

Leukemia, 2013-01, Vol.27 (1), p.75-81

2013

Volltextzugriff (PDF)

The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants

Bone marrow transplantation (Basingstoke), 2005-03, Vol.35 (6), p.609-617

2005

Volltextzugriff (PDF)

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres

British journal of haematology, 2001-04, Vol.113 (1), p.209-216

2001

Volltextzugriff (PDF)

Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia : first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 1998-05, Vol.21 (10), p.995-1003

1998

Volltextzugriff (PDF)

Fusion of NUP214 to ABL1 on amplified episomes in T-ALL - implications for treatment

Leukemia, 2005-09, Vol.19 (9), p.1680-1681

2005

Volltextzugriff (PDF)

Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants

Bone marrow transplantation (Basingstoke), 2017-05, Vol.52 (5), p.717-725

2017

Volltextzugriff (PDF)

Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning – evidence for a superior outcome using melphalan combined with total body irradiation

British journal of haematology, 2005-02, Vol.128 (4), p.496-502

2005

Volltextzugriff (PDF)

Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak

Bone marrow transplantation (Basingstoke), 2007-05, Vol.39 (10), p.623-629

2007

Volltextzugriff (PDF)

Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia

Blood, 1999-07, Vol.94 (2), p.733-740

1999

Volltextzugriff (PDF)

1 – 25 von 5.106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.636)
Mit Volltextzugriff
(4.480)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.606)
Life Sciences & Biomedicine
(2.565)
Humans
(2.068)
Female
(1.289)
Male
(1.214)
Biological And Medical Sciences
(1.118)
Medical Sciences
(893)
Middle Aged
(803)
Adult
(772)
Physical Sciences
(764)
Animals
(616)
Aged
(550)
Technology
(325)
Adolescent
(308)
Astronomy & Astrophysics
(303)
Oncology
(289)
Fundamental And Applied Biological Sciences. Psychology
(286)
Physics
(260)
General & Internal Medicine
(256)
Risk Factors
(252)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

Comparative analysis of DNA extraction and PCR product purification methods for cervicovaginal microbiome analysis using cpn60 microbial profiling

Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial

Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide

Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia

Gardnerella subgroup dominant microbiomes are associated with divergent cervicovaginal immune responses in a longitudinal cohort of Kenyan women

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry

Acute disseminated encephalomyelitis following allo-SCT: central nervous system manifestation of GVHD

DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412

Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation

Primary Transplantation of Allogeneic Peripheral Blood Progenitor Cells Mobilized by Filgrastim (Granulocyte Colony-Stimulating Factor)

Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia

Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant

Interleukin-1β maintains an apoptosis-resistant phenotype in the blast cells of acute myeloid leukaemia via multiple pathways

The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison

The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres

Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia : first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation

Fusion of NUP214 to ABL1 on amplified episomes in T-ALL - implications for treatment

Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants

Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning – evidence for a superior outcome using melphalan combined with total body irradiation

Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak

Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia

Suchergebnisse filtern